BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 36756380)

  • 1. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
    Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiz M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Macklon KLT
    Hum Reprod Open; 2023; 2023(1):hoac057. PubMed ID: 36756380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.
    Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiž M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Tryde Macklon KL
    Facts Views Vis Obgyn; 2023 Mar; 15(1):3-23. PubMed ID: 37010330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.
    Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiž M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Tryde Macklon KL
    Facts Views Vis Obgyn; 2023 Feb; 15(1):. PubMed ID: 36739613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good practice recommendations on add-ons in reproductive medicine†.
    ; Lundin K; Bentzen JG; Bozdag G; Ebner T; Harper J; Le Clef N; Moffett A; Norcross S; Polyzos NP; Rautakallio-Hokkanen S; Sfontouris I; Sermon K; Vermeulen N; Pinborg A
    Hum Reprod; 2023 Nov; 38(11):2062-2104. PubMed ID: 37747409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.
    Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiz M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Macklon KLT
    Int J Gynecol Cancer; 2023 Feb; 33(2):208-222. PubMed ID: 36746507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESHRE guideline: endometriosis.
    Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
    Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based guideline: unexplained infertility†.
    ; Romualdi D; Ata B; Bhattacharya S; Bosch E; Costello M; Gersak K; Homburg R; Mincheva M; Norman RJ; Piltonen T; Dos Santos-Ribeiro S; Scicluna D; Somers S; Sunkara SK; Verhoeve HR; Le Clef N
    Hum Reprod; 2023 Oct; 38(10):1881-1890. PubMed ID: 37599566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESHRE good practice recommendations on recurrent implantation failure.
    ; Cimadomo D; de Los Santos MJ; Griesinger G; Lainas G; Le Clef N; McLernon DJ; Montjean D; Toth B; Vermeulen N; Macklon N
    Hum Reprod Open; 2023; 2023(3):hoad023. PubMed ID: 37332387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESHRE guideline: number of embryos to transfer during IVF/ICSI†.
    ; Alteri A; Arroyo G; Baccino G; Craciunas L; De Geyter C; Ebner T; Koleva M; Kordic K; Mcheik S; Mertes H; Pavicic Baldani D; Rodriguez-Wallberg KA; Rugescu I; Santos-Ribeiro S; Tilleman K; Woodward B; Vermeulen N; Veleva Z
    Hum Reprod; 2024 Apr; 39(4):647-657. PubMed ID: 38364208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESHRE guideline: ovarian stimulation for IVF/ICSI
    Ovarian Stimulation TEGGO; Bosch E; Broer S; Griesinger G; Grynberg M; Humaidan P; Kolibianakis E; Kunicki M; La Marca A; Lainas G; Le Clef N; Massin N; Mastenbroek S; Polyzos N; Sunkara SK; Timeva T; Töyli M; Urbancsek J; Vermeulen N; Broekmans F
    Hum Reprod Open; 2020; 2020(2):hoaa009. PubMed ID: 32395637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESHRE guideline: female fertility preservation.
    ; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
    Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESHRE guideline: recurrent pregnancy loss: an update in 2022.
    ; Bender Atik R; Christiansen OB; Elson J; Kolte AM; Lewis S; Middeldorp S; Mcheik S; Peramo B; Quenby S; Nielsen HS; van der Hoorn ML; Vermeulen N; Goddijn M
    Hum Reprod Open; 2023; 2023(1):hoad002. PubMed ID: 36873081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESHRE survey results and good practice recommendations on managing chromosomal mosaicism.
    ; De Rycke M; Capalbo A; Coonen E; Coticchio G; Fiorentino F; Goossens V; Mcheik S; Rubio C; Sermon K; Sfontouris I; Spits C; Vermeesch JR; Vermeulen N; Wells D; Zambelli F; Kakourou G
    Hum Reprod Open; 2022; 2022(4):hoac044. PubMed ID: 36349144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESHRE guideline: medically assisted reproduction in patients with a viral infection/disease.
    ; Mocanu E; Drakeley A; Kupka MS; Lara-Molina EE; Le Clef N; Ombelet W; Patrat C; Pennings G; Semprini AE; Tilleman K; Tognon M; Tonch N; Woodward B
    Hum Reprod Open; 2021; 2021(4):hoab037. PubMed ID: 36733615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
    Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
    Radiother Oncol; 2021 Jan; 154():327-353. PubMed ID: 33712263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
    Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X
    Virchows Arch; 2021 Feb; 478(2):153-190. PubMed ID: 33604759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
    Int J Gynecol Cancer; 2018 May; 28(4):641-655. PubMed ID: 29688967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.